Sign in
Taking peopleNo phase

Long-term follow-up of giant cell arteritis and polymyalgia rheumatica complications

Follows adults with giant cell arteritis or polymyalgia rheumatica for aorta and steroid side effects.

Key facts

Who runs it
Wuerzburg University Hospital
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Giant Cell Arteritis - Ways to Precision Medicine
Status
Recruiting
People taking part
400 people, planned
Started
14 Nov 2025
Expected to end
31 Jul 2033
Type of study
Observational, 2 groups
Record updated
22 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). It follows them over a long time to track problems of the aorta and side effects of glucocorticoid (steroid) treatment.

Age
18 years or older
Sex
All sexes
Disease stage
A main diagnosis of GCA or PMR
Earlier treatment
Both people already on immunosuppressive therapy and new patients can join. New patients preferably have not had immunosuppressive therapy, but this is not required.

Main reasons for not taking part

  • Under 18 years of age
  • Unable to give consent

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Age greater or similar to 18 years
  • Primary diagnosis of GCA or PMR

Who cannot take part

  • Age under 18 years
  • lack of capacity to consent

This trial is currently available in Germany.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).

The 2 groups in the trial

  • Known patients

    Patients, who are already known and had regular visits in the outpatient rheumatology department of the Würzburg university hospital. These patients already receive immunosuppressive therapy.

  • New patients

    Patients who have not yet been treated by the outpatient rheumatology department of the Würzburg university hospital, preferably but not limited to immunosuppressive therapy-naive patients.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Riesenzellarteriitis - Wege Zur "Precision Medicine"
Plain-language title
Long-term follow-up of giant cell arteritis and polymyalgia rheumatica complicationsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
22 December 2025